Renaissance Technologies
FHTX icon

Renaissance Technologies’s Foghorn Therapeutics FHTX Stock Holding History

Renaissance Technologies’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Sell
377,936
-28,489
-7% -$126K ﹤0.01% 2000
2026
Q1 		$1.94M Buy
406,425
+108,689
+37% +$597K ﹤0.01% 1913
2025
Q4 		$1.61M Buy
297,736
+179,500
+152% +$814K ﹤0.01% 2004
2025
Q3 		$578K Buy
118,236
+55,600
+89% +$295K ﹤0.01% 2728
2025
Q2 		$294K Buy
62,636
+5,400
+9% +$22.6K ﹤0.01% 3044
2025
Q1 		$209K Buy
57,236
+9,500
+20% +$43.3K ﹤0.01% 3062
2024
Q4 		$225K Buy
47,736
+22,500
+89% +$164K ﹤0.01% 3132
2024
Q3 		$235K Buy
25,236
+14,536
+136% +$105K ﹤0.01% 3073
2024
Q2 		$61.5K Buy
+10,700
New +$63.7K ﹤0.01% 3259

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Renaissance Technologies's FHTX Position: Q2 2026 in Review

Renaissance Technologies reduced its Foghorn Therapeutics (FHTX) stake by 7% in Q2 2026, selling an estimated $126K and leaving 377,936 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

Renaissance Technologies first reported a position in FHTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.94M in Q1 2026. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Renaissance Technologies held 377,936 shares of Foghorn Therapeutics worth $1.84M as of Q2 2026.
  • Renaissance Technologies sold 28,489 Foghorn Therapeutics shares in Q2 2026, an estimated $126K.
  • Foghorn Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2000 holding.
  • Renaissance Technologies first reported a position in Foghorn Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Renaissance Technologies's Foghorn Therapeutics position peaked at $1.94M in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.